Pilot purpose
The MediFlow pilot gives selected clinical teams early access so they can validate patient workflows, scheduling, document management, vitals, AI-assisted operations, and organization administration in a controlled environment.
MediFlow pilots are intended for selected clinicians and organizations to evaluate the product, validate workflows, and provide feedback before broader availability.
Pilot participation is controlled by scope, usage limits, data rules, privacy expectations, feedback loops, and written agreement. These terms are product guidance, not a final legal contract.
Product guidance only. Roadmap and pilot details depend on shipped evidence, commercial scope, and legal review.
The MediFlow pilot gives selected clinical teams early access so they can validate patient workflows, scheduling, document management, vitals, AI-assisted operations, and organization administration in a controlled environment.
Pilot work should use synthetic or non-production data unless production PHI is expressly permitted in writing. Production PHI use requires appropriate legal agreements, provider configuration, access controls, retention policy, and compliance review.
At the end of the pilot, the organization may continue under a written launch agreement, extend by written agreement, export permitted data, or request deletion according to the agreed retention policy.